RELATING TO ACCESS TO TREATMENT FOR TERMINALLY ILL PATIENTS.
Summary
Beginning on January 1, 2025, permits manufacturers of investigational drugs or biological products to make these drugs and products available to terminally ill patients under certain conditions.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jan 2024
Committee Review
Floor Vote
Governor
Introduced Jan 10, 2024
Last action Jan 17, 2024
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
3
Key actions
0
Committee
1
Jan 17, 2024
Committee
Referred to HHS, CPN/JDC.
upper
Jan 17, 2024
Introduced
Introduced and passed First Reading.
upper
Jan 10, 2024
Introduced
Pending Introduction.
upper
7 primary · 0 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about SB 2023
Scope: HI
Hi! I can help you understand SB 2023. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline